Magnetically controlled release of cisplatin from superparamagnetic starch nanoparticles
1Bose Memorial Research Laboratory, Department of Chemistry, Government Autonomous Science College, Jabalpur, MP 482003, India.
Carbohydrate Polymers
|October 19, 2021
Summary
Researchers developed novel superparamagnetic starch nanoparticles for targeted cancer drug delivery. These nanoparticles loaded with cisplatin show controlled release, potentially improving treatment efficacy and reducing side effects.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Developing effective drug delivery systems is crucial for improving cancer therapy.
- Superparamagnetic nanoparticles offer potential for targeted drug delivery due to their responsiveness to external magnetic fields.
- Starch-based nanoparticles present a biocompatible and biodegradable platform for drug encapsulation.
Purpose of the Study:
- To synthesize and characterize novel superparamagnetic nanoparticles using crosslinked starch and iron oxide.
- To load the anticancer drug cisplatin into these nanoparticles and investigate its release kinetics.
- To evaluate the potential of these nanoparticles for targeted and controlled drug delivery.
Main Methods:
- Synthesis of crosslinked starch nanoparticles impregnated with nanosized iron oxide.
- Characterization using Fourier Transform Infrared (FTIR) spectroscopy, Transmission Electron Microscopy (TEM), X-ray diffraction, and magnetization studies.
- Spectrophotometric investigation of cisplatin release kinetics at physiological pH (7.4).
Main Results:
- Superparamagnetic starch nanoparticles with particle sizes ranging from 20-90nm were successfully prepared.
- Drug release kinetics were influenced by nanoparticle composition, pH, temperature, and applied magnetic field.
- Characterization confirmed the successful impregnation of iron oxide within the starch matrix.
Conclusions:
- The developed superparamagnetic starch nanoparticles are a promising platform for targeted and controlled delivery of cisplatin.
- This approach has the potential to enhance anticancer drug efficacy while minimizing systemic side effects.
- Further research into magnetic targeting strategies could optimize drug delivery and patient outcomes.


